Jan Pyman - Concepedia

Author

Jan Pyman

Also Known As

A. deFazio, Erin Tidball, J Pyman, J. Pyman, Jan M. Pyman, Jan PYMAN, Jan Pyman, M. Robbie, Marc T. Goodman, Michael Quinn

Publications

4.7K

Citations

H-Index

Concepts

All Affiliations

Royal Women's Hospital The University of Melbourne Peter MacCallum Cancer Centre The Royal Melbourne Hospital Murdoch Children's Research Institute

About

Jan Pyman is an author at Royal Women's Hospital specializing in medicine, obstetrics, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	7	188
2	Obstetrics	4	5	133
3	Pathology	3	4	134
4	Public Health	2	2	33
5	Epidemiology	1	1	15

Jan Pyman

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial Stephanie M. de Boer, Melanie Powell, Linda Mileshkin, The Lancet Oncology	2018	599
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial Stephanie M. de Boer, Melanie Powell, Linda Mileshkin, The Lancet Oncology	2019	432
Isolation and Characterization of Tumor Cells from the Ascites of Ovarian Cancer Patients: Molecular Phenotype of Chemoresistant Ovarian Tumors Ardian Latifi, Rodney B. Luwor, Maree Bilandzic, PLoS ONE	2012	234
The molecular origin and taxonomy of mucinous ovarian carcinoma Dane Cheasley, Matthew J. Wakefield, Georgina L. Ryland, Nature Communications	2019	180
p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial Lisa Vermij, Alicia León‐Castillo, Naveena Singh, Modern Pathology	2022	140
Molecular correlates of platinum response in human high‐grade serous ovarian cancer patient‐derived xenografts Monique Topp, Lynne Hartley, Michele Cook, Molecular Oncology	2014	138
Therapeutic options for mucinous ovarian carcinoma Kylie L. Gorringe, Dane Cheasley, Matthew J. Wakefield, Gynecologic Oncology	2020	89
Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer Stephanie M. de Boer, Bastiaan G. Wortman, Tjalling Bosse, Annals of Oncology	2017	85
Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination Julia Brotherton, Sepehr N. Tabrizi, Samuel Phillips, International Journal of Cancer	2017	65
Persistent trophoblast disease following partial molar pregnancy Sabien WIESMA, Linda G.W. Kerkmeijer, Ruud L.M. Bekkers, Australian and New Zealand Journal of Obstetrics and Gynaecology	2006	64

Page 1